TCG Crossover GP II, LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-12 6:09 pm Purchase | 2026-05-05 | 13G | AVALO THERAPEUTICS INC PAR AVTX | TCG Crossover GP II, LLC | 3,017,120 7.900% | 3,017,120 (New Position) | Filing |